BAZZICHI, L. et al. Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study. Reumatismo, [S. l.], v. 66, n. 3, p. 224–232, 2014. DOI: 10.4081/reumatismo.2014.748. Disponível em: https://www.reumatismo.org/reuma/article/view/reumatismo.2014.748. Acesso em: 27 nov. 2024.